Judy H. Borovicka

Multicenter prospective cohort study of the incidence of adverse events associated with cosmetic dermatologic procedures: lasers, energy devices, and injectable neurotoxins and fillers.

K. Arndt, J. Dover, M. Kaminer, 2015, JAMA dermatology.

Interstitial granulomatous dermatitis and palisaded neutrophilic granulomatous dermatitis.

D. Mehregan, D. Mehregan, Taryn Huizenga, 2018, Cutis.

Economic burden of dermatologic adverse events induced by molecularly targeted cancer agents.

D. West, M. Lacouture, M. Kwasny, 2011, Archives of dermatology.

Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL).

D. West, R. Kundu, David E Victorson, 2013, Journal of the American Academy of Dermatology.

Dermatologic Therapeutics and Formulations

D. West, J. Gordon, J. Borovicka, 2013 .

Clinical severity does not reliably predict quality of life in women with alopecia areata, telogen effluvium, or androgenic alopecia.

A. Rademaker, D. West, M. Colavincenzo, 2012, Journal of the American Academy of Dermatology.

Safety of a novel microneedle device applied to facial skin: a subject- and rater-blinded, sham-controlled, randomized trial.

D. West, B. Nardone, Murad Alam, 2012, Archives of dermatology.

Scarring alopecia: clinical and pathologic study of 54 African‐American women

D. Mehregan, C. Prince, Judy H. Borovicka, 2009, International journal of dermatology.